nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—hypothyroidism	0.608	1	CbGaD
Loperamide—CYP2C8—Levothyroxine—hypothyroidism	0.0485	0.227	CbGbCtD
Loperamide—CYP2C8—Liotrix—hypothyroidism	0.0473	0.222	CbGbCtD
Loperamide—ABCB1—Levothyroxine—hypothyroidism	0.0328	0.154	CbGbCtD
Loperamide—ABCB1—Liothyronine—hypothyroidism	0.0328	0.154	CbGbCtD
Loperamide—ABCB1—Liotrix—hypothyroidism	0.032	0.15	CbGbCtD
Loperamide—CYP3A4—Levothyroxine—hypothyroidism	0.0197	0.0922	CbGbCtD
Loperamide—CACNA1A—cerebellar cortex—hypothyroidism	0.0114	0.142	CbGeAlD
Loperamide—POMC—brown adipose tissue—hypothyroidism	0.0101	0.125	CbGeAlD
Loperamide—Distention—Liotrix—hypothyroidism	0.0073	0.156	CcSEcCtD
Loperamide—POMC—urine—hypothyroidism	0.00637	0.079	CbGeAlD
Loperamide—POMC—nerve—hypothyroidism	0.0044	0.0545	CbGeAlD
Loperamide—CACNA1A—nerve—hypothyroidism	0.0042	0.0521	CbGeAlD
Loperamide—Abdominal bloating—Liotrix—hypothyroidism	0.00361	0.0772	CcSEcCtD
Loperamide—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.00346	0.074	CcSEcCtD
Loperamide—Abdominal cramps—Levothyroxine—hypothyroidism	0.00346	0.074	CcSEcCtD
Loperamide—Abdominal cramps—Liotrix—hypothyroidism	0.00255	0.0544	CcSEcCtD
Loperamide—POMC—adrenal cortex—hypothyroidism	0.00169	0.0209	CbGeAlD
Loperamide—OPRM1—nerve—hypothyroidism	0.00165	0.0205	CbGeAlD
Loperamide—POMC—heart—hypothyroidism	0.00163	0.0202	CbGeAlD
Loperamide—POMC—cardiovascular system—hypothyroidism	0.00154	0.0191	CbGeAlD
Loperamide—POMC—gonad—hypothyroidism	0.0014	0.0173	CbGeAlD
Loperamide—POMC—pituitary gland—hypothyroidism	0.00136	0.0169	CbGeAlD
Loperamide—POMC—adrenal gland—hypothyroidism	0.00122	0.0151	CbGeAlD
Loperamide—POMC—blood—hypothyroidism	0.00122	0.0151	CbGeAlD
Loperamide—CALM2—nerve—hypothyroidism	0.0012	0.0149	CbGeAlD
Loperamide—CALM1—nerve—hypothyroidism	0.0012	0.0148	CbGeAlD
Loperamide—POMC—thyroid gland—hypothyroidism	0.00118	0.0146	CbGeAlD
Loperamide—CACNA1A—adrenal gland—hypothyroidism	0.00116	0.0144	CbGeAlD
Loperamide—POMC—female gonad—hypothyroidism	0.00114	0.0141	CbGeAlD
Loperamide—Abdominal distension—Liotrix—hypothyroidism	0.00109	0.0232	CcSEcCtD
Loperamide—POMC—testis—hypothyroidism	0.00101	0.0125	CbGeAlD
Loperamide—CYP3A4—urine—hypothyroidism	0.000977	0.0121	CbGeAlD
Loperamide—CACNA1A—testis—hypothyroidism	0.000962	0.0119	CbGeAlD
Loperamide—CYP2D6—urine—hypothyroidism	0.000961	0.0119	CbGeAlD
Loperamide—POMC—liver—hypothyroidism	0.000953	0.0118	CbGeAlD
Loperamide—Angioedema—Dextrothyroxine—hypothyroidism	0.000934	0.02	CcSEcCtD
Loperamide—Angioedema—Levothyroxine—hypothyroidism	0.000934	0.02	CcSEcCtD
Loperamide—POMC—cerebellum—hypothyroidism	0.000931	0.0115	CbGeAlD
Loperamide—CACNA1A—cerebellum—hypothyroidism	0.000888	0.011	CbGeAlD
Loperamide—Flatulence—Liotrix—hypothyroidism	0.000741	0.0158	CcSEcCtD
Loperamide—Fatigue—Dextrothyroxine—hypothyroidism	0.000719	0.0154	CcSEcCtD
Loperamide—Fatigue—Levothyroxine—hypothyroidism	0.000719	0.0154	CcSEcCtD
Loperamide—Angioedema—Liotrix—hypothyroidism	0.000687	0.0147	CcSEcCtD
Loperamide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000682	0.0146	CcSEcCtD
Loperamide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000682	0.0146	CcSEcCtD
Loperamide—Urticaria—Dextrothyroxine—hypothyroidism	0.000663	0.0142	CcSEcCtD
Loperamide—Urticaria—Levothyroxine—hypothyroidism	0.000663	0.0142	CcSEcCtD
Loperamide—Loss of consciousness—Liotrix—hypothyroidism	0.000661	0.0141	CcSEcCtD
Loperamide—Abdominal pain—Levothyroxine—hypothyroidism	0.000659	0.0141	CcSEcCtD
Loperamide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000659	0.0141	CcSEcCtD
Loperamide—Anaphylactic shock—Liotrix—hypothyroidism	0.000614	0.0131	CcSEcCtD
Loperamide—Asthenia—Dextrothyroxine—hypothyroidism	0.000598	0.0128	CcSEcCtD
Loperamide—Asthenia—Levothyroxine—hypothyroidism	0.000598	0.0128	CcSEcCtD
Loperamide—Pruritus—Levothyroxine—hypothyroidism	0.00059	0.0126	CcSEcCtD
Loperamide—Pruritus—Dextrothyroxine—hypothyroidism	0.00059	0.0126	CcSEcCtD
Loperamide—CALM3—adrenal cortex—hypothyroidism	0.000587	0.00728	CbGeAlD
Loperamide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000571	0.0122	CcSEcCtD
Loperamide—Diarrhoea—Levothyroxine—hypothyroidism	0.000571	0.0122	CcSEcCtD
Loperamide—CALM3—heart—hypothyroidism	0.000568	0.00704	CbGeAlD
Loperamide—Vomiting—Levothyroxine—hypothyroidism	0.00053	0.0113	CcSEcCtD
Loperamide—Vomiting—Dextrothyroxine—hypothyroidism	0.00053	0.0113	CcSEcCtD
Loperamide—Fatigue—Liotrix—hypothyroidism	0.000529	0.0113	CcSEcCtD
Loperamide—Rash—Levothyroxine—hypothyroidism	0.000526	0.0112	CcSEcCtD
Loperamide—Rash—Dextrothyroxine—hypothyroidism	0.000526	0.0112	CcSEcCtD
Loperamide—Dermatitis—Levothyroxine—hypothyroidism	0.000525	0.0112	CcSEcCtD
Loperamide—Dermatitis—Dextrothyroxine—hypothyroidism	0.000525	0.0112	CcSEcCtD
Loperamide—Constipation—Liotrix—hypothyroidism	0.000525	0.0112	CcSEcCtD
Loperamide—Headache—Levothyroxine—hypothyroidism	0.000523	0.0112	CcSEcCtD
Loperamide—Headache—Dextrothyroxine—hypothyroidism	0.000523	0.0112	CcSEcCtD
Loperamide—Gastrointestinal pain—Liotrix—hypothyroidism	0.000502	0.0107	CcSEcCtD
Loperamide—Nausea—Levothyroxine—hypothyroidism	0.000495	0.0106	CcSEcCtD
Loperamide—Nausea—Dextrothyroxine—hypothyroidism	0.000495	0.0106	CcSEcCtD
Loperamide—OPRK1—cerebellum—hypothyroidism	0.000492	0.00611	CbGeAlD
Loperamide—Urticaria—Liotrix—hypothyroidism	0.000487	0.0104	CcSEcCtD
Loperamide—Abdominal pain—Liotrix—hypothyroidism	0.000485	0.0104	CcSEcCtD
Loperamide—CALM3—pituitary gland—hypothyroidism	0.000474	0.00588	CbGeAlD
Loperamide—CALM2—adrenal cortex—hypothyroidism	0.000461	0.00572	CbGeAlD
Loperamide—CALM1—adrenal cortex—hypothyroidism	0.000459	0.00569	CbGeAlD
Loperamide—OPRM1—blood—hypothyroidism	0.000458	0.00569	CbGeAlD
Loperamide—Hypersensitivity—Liotrix—hypothyroidism	0.000452	0.00966	CcSEcCtD
Loperamide—CALM2—heart—hypothyroidism	0.000446	0.00553	CbGeAlD
Loperamide—CALM1—heart—hypothyroidism	0.000444	0.0055	CbGeAlD
Loperamide—Asthenia—Liotrix—hypothyroidism	0.00044	0.00941	CcSEcCtD
Loperamide—Pruritus—Liotrix—hypothyroidism	0.000434	0.00928	CcSEcCtD
Loperamide—CALM3—adrenal gland—hypothyroidism	0.000424	0.00526	CbGeAlD
Loperamide—CALM3—blood—hypothyroidism	0.000424	0.00526	CbGeAlD
Loperamide—CALM2—cardiovascular system—hypothyroidism	0.000421	0.00522	CbGeAlD
Loperamide—Diarrhoea—Liotrix—hypothyroidism	0.00042	0.00897	CcSEcCtD
Loperamide—CALM1—cardiovascular system—hypothyroidism	0.000419	0.00519	CbGeAlD
Loperamide—CALM3—thyroid gland—hypothyroidism	0.000409	0.00507	CbGeAlD
Loperamide—Dizziness—Liotrix—hypothyroidism	0.000406	0.00867	CcSEcCtD
Loperamide—CALM3—female gonad—hypothyroidism	0.000395	0.0049	CbGeAlD
Loperamide—Vomiting—Liotrix—hypothyroidism	0.00039	0.00834	CcSEcCtD
Loperamide—Rash—Liotrix—hypothyroidism	0.000387	0.00827	CcSEcCtD
Loperamide—Dermatitis—Liotrix—hypothyroidism	0.000387	0.00826	CcSEcCtD
Loperamide—Headache—Liotrix—hypothyroidism	0.000384	0.00821	CcSEcCtD
Loperamide—CALM2—gonad—hypothyroidism	0.000382	0.00474	CbGeAlD
Loperamide—CALM1—gonad—hypothyroidism	0.00038	0.00471	CbGeAlD
Loperamide—OPRM1—testis—hypothyroidism	0.000379	0.0047	CbGeAlD
Loperamide—CALM2—pituitary gland—hypothyroidism	0.000373	0.00462	CbGeAlD
Loperamide—CALM1—pituitary gland—hypothyroidism	0.000371	0.0046	CbGeAlD
Loperamide—Nausea—Liotrix—hypothyroidism	0.000364	0.00779	CcSEcCtD
Loperamide—CALM3—testis—hypothyroidism	0.00035	0.00435	CbGeAlD
Loperamide—CYP2B6—adrenal cortex—hypothyroidism	0.000343	0.00425	CbGeAlD
Loperamide—CALM2—adrenal gland—hypothyroidism	0.000333	0.00413	CbGeAlD
Loperamide—CALM2—blood—hypothyroidism	0.000333	0.00413	CbGeAlD
Loperamide—CYP2B6—heart—hypothyroidism	0.000331	0.00411	CbGeAlD
Loperamide—CALM3—liver—hypothyroidism	0.000331	0.00411	CbGeAlD
Loperamide—CALM1—adrenal gland—hypothyroidism	0.000331	0.00411	CbGeAlD
Loperamide—CALM1—blood—hypothyroidism	0.000331	0.00411	CbGeAlD
Loperamide—CALM3—cerebellum—hypothyroidism	0.000324	0.00401	CbGeAlD
Loperamide—CALM2—thyroid gland—hypothyroidism	0.000321	0.00398	CbGeAlD
Loperamide—CALM1—thyroid gland—hypothyroidism	0.00032	0.00396	CbGeAlD
Loperamide—CYP2B6—cardiovascular system—hypothyroidism	0.000313	0.00388	CbGeAlD
Loperamide—CALM2—female gonad—hypothyroidism	0.00031	0.00385	CbGeAlD
Loperamide—CALM1—female gonad—hypothyroidism	0.000309	0.00383	CbGeAlD
Loperamide—CYP2C8—pituitary gland—hypothyroidism	0.000309	0.00383	CbGeAlD
Loperamide—CYP2B6—gonad—hypothyroidism	0.000284	0.00352	CbGeAlD
Loperamide—CYP2C8—blood—hypothyroidism	0.000276	0.00342	CbGeAlD
Loperamide—CALM2—testis—hypothyroidism	0.000275	0.00341	CbGeAlD
Loperamide—CALM1—testis—hypothyroidism	0.000274	0.0034	CbGeAlD
Loperamide—CALM2—liver—hypothyroidism	0.00026	0.00323	CbGeAlD
Loperamide—CALM1—liver—hypothyroidism	0.000259	0.00321	CbGeAlD
Loperamide—CALM2—cerebellum—hypothyroidism	0.000254	0.00315	CbGeAlD
Loperamide—CALM1—cerebellum—hypothyroidism	0.000253	0.00314	CbGeAlD
Loperamide—CYP2B6—adrenal gland—hypothyroidism	0.000247	0.00307	CbGeAlD
Loperamide—CYP2B6—blood—hypothyroidism	0.000247	0.00307	CbGeAlD
Loperamide—CYP2C8—testis—hypothyroidism	0.000228	0.00283	CbGeAlD
Loperamide—CYP2C8—liver—hypothyroidism	0.000216	0.00267	CbGeAlD
Loperamide—CYP2B6—testis—hypothyroidism	0.000205	0.00254	CbGeAlD
Loperamide—CYP2B6—liver—hypothyroidism	0.000193	0.0024	CbGeAlD
Loperamide—CYP3A4—blood—hypothyroidism	0.000187	0.00232	CbGeAlD
Loperamide—CYP2D6—blood—hypothyroidism	0.000184	0.00228	CbGeAlD
Loperamide—ABCB1—adrenal cortex—hypothyroidism	0.000183	0.00227	CbGeAlD
Loperamide—ABCB1—heart—hypothyroidism	0.000177	0.0022	CbGeAlD
Loperamide—CYP2D6—female gonad—hypothyroidism	0.000171	0.00213	CbGeAlD
Loperamide—ABCB1—cardiovascular system—hypothyroidism	0.000167	0.00207	CbGeAlD
Loperamide—CYP2D6—testis—hypothyroidism	0.000152	0.00189	CbGeAlD
Loperamide—ABCB1—gonad—hypothyroidism	0.000152	0.00188	CbGeAlD
Loperamide—ABCB1—pituitary gland—hypothyroidism	0.000148	0.00184	CbGeAlD
Loperamide—CYP3A4—liver—hypothyroidism	0.000146	0.00181	CbGeAlD
Loperamide—CYP2D6—liver—hypothyroidism	0.000144	0.00178	CbGeAlD
Loperamide—CYP2D6—cerebellum—hypothyroidism	0.00014	0.00174	CbGeAlD
Loperamide—ABCB1—adrenal gland—hypothyroidism	0.000132	0.00164	CbGeAlD
Loperamide—ABCB1—blood—hypothyroidism	0.000132	0.00164	CbGeAlD
Loperamide—ABCB1—thyroid gland—hypothyroidism	0.000128	0.00158	CbGeAlD
Loperamide—ABCB1—female gonad—hypothyroidism	0.000123	0.00153	CbGeAlD
Loperamide—ABCB1—testis—hypothyroidism	0.000109	0.00136	CbGeAlD
Loperamide—ABCB1—liver—hypothyroidism	0.000103	0.00128	CbGeAlD
Loperamide—ABCB1—cerebellum—hypothyroidism	0.000101	0.00125	CbGeAlD
Loperamide—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.42e-05	0.00124	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	6.41e-05	0.00124	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	6.41e-05	0.00124	CbGpPWpGaD
Loperamide—CALM3—DAP12 signaling—VAV3—hypothyroidism	6.36e-05	0.00123	CbGpPWpGaD
Loperamide—CALM2—DAP12 signaling—VAV3—hypothyroidism	6.15e-05	0.00119	CbGpPWpGaD
Loperamide—CALM1—DAP12 signaling—VAV3—hypothyroidism	6.15e-05	0.00119	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—SLC5A5—hypothyroidism	6.08e-05	0.00118	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—AVP—hypothyroidism	6.06e-05	0.00118	CbGpPWpGaD
Loperamide—CALM3—DAP12 interactions—VAV3—hypothyroidism	5.98e-05	0.00116	CbGpPWpGaD
Loperamide—CALM3—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	5.98e-05	0.00116	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TRH—hypothyroidism	5.92e-05	0.00115	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	5.9e-05	0.00114	CbGpPWpGaD
Loperamide—OPRM1—Peptide ligand-binding receptors—POMC—hypothyroidism	5.84e-05	0.00113	CbGpPWpGaD
Loperamide—OPRK1—G alpha (i) signalling events—POMC—hypothyroidism	5.83e-05	0.00113	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—TSHB—hypothyroidism	5.81e-05	0.00113	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—TSHR—hypothyroidism	5.81e-05	0.00113	CbGpPWpGaD
Loperamide—CALM2—DAP12 interactions—VAV3—hypothyroidism	5.79e-05	0.00112	CbGpPWpGaD
Loperamide—CALM1—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	5.79e-05	0.00112	CbGpPWpGaD
Loperamide—CALM1—DAP12 interactions—VAV3—hypothyroidism	5.79e-05	0.00112	CbGpPWpGaD
Loperamide—CALM2—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	5.79e-05	0.00112	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TRH—hypothyroidism	5.72e-05	0.00111	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—AVP—hypothyroidism	5.32e-05	0.00103	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.29e-05	0.00103	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TSHB—hypothyroidism	5.28e-05	0.00102	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TSHR—hypothyroidism	5.28e-05	0.00102	CbGpPWpGaD
Loperamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.27e-05	0.00102	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—PRL—hypothyroidism	5.2e-05	0.00101	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TRH—hypothyroidism	5.19e-05	0.00101	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.18e-05	0.00101	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TSHB—hypothyroidism	5.1e-05	0.000988	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TSHR—hypothyroidism	5.1e-05	0.000988	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	5.01e-05	0.000971	CbGpPWpGaD
Loperamide—OPRM1—G alpha (i) signalling events—POMC—hypothyroidism	4.93e-05	0.000956	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	4.84e-05	0.000939	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	4.84e-05	0.000939	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TRH—hypothyroidism	4.83e-05	0.000937	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—VAV3—hypothyroidism	4.81e-05	0.000932	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—IYD—hypothyroidism	4.75e-05	0.000921	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CLTC—hypothyroidism	4.73e-05	0.000918	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.64e-05	0.000899	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—AVP—hypothyroidism	4.63e-05	0.000898	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TSHB—hypothyroidism	4.63e-05	0.000897	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TSHR—hypothyroidism	4.63e-05	0.000897	CbGpPWpGaD
Loperamide—CALM3—Metabolism—IYD—hypothyroidism	4.62e-05	0.000896	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CLTC—hypothyroidism	4.58e-05	0.000888	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CLTC—hypothyroidism	4.58e-05	0.000888	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—AVP—hypothyroidism	4.49e-05	0.000871	CbGpPWpGaD
Loperamide—CALM2—Metabolism—IYD—hypothyroidism	4.47e-05	0.000867	CbGpPWpGaD
Loperamide—CALM1—Metabolism—IYD—hypothyroidism	4.47e-05	0.000867	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TRH—hypothyroidism	4.39e-05	0.000851	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TSHB—hypothyroidism	4.31e-05	0.000835	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TSHR—hypothyroidism	4.31e-05	0.000835	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.3e-05	0.000833	CbGpPWpGaD
Loperamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.25e-05	0.000824	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—VAV3—hypothyroidism	4.07e-05	0.00079	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CLTC—hypothyroidism	4.05e-05	0.000785	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ATP5O—hypothyroidism	4.04e-05	0.000783	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—POMC—hypothyroidism	4.03e-05	0.000781	CbGpPWpGaD
Loperamide—CYP2B6—Biological oxidations—POMC—hypothyroidism	4.03e-05	0.000781	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—IYD—hypothyroidism	4.02e-05	0.00078	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—VAV3—hypothyroidism	3.94e-05	0.000764	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—VAV3—hypothyroidism	3.94e-05	0.000764	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ATP5O—hypothyroidism	3.93e-05	0.000762	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	3.92e-05	0.00076	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TSHB—hypothyroidism	3.91e-05	0.000758	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TSHR—hypothyroidism	3.91e-05	0.000758	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ATP5O—hypothyroidism	3.8e-05	0.000737	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ATP5O—hypothyroidism	3.8e-05	0.000737	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—TPO—hypothyroidism	3.8e-05	0.000736	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—SH2B3—hypothyroidism	3.76e-05	0.000729	CbGpPWpGaD
Loperamide—CALM3—Metabolism—TPO—hypothyroidism	3.69e-05	0.000716	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—SH2B3—hypothyroidism	3.64e-05	0.000705	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—SH2B3—hypothyroidism	3.64e-05	0.000705	CbGpPWpGaD
Loperamide—CALM1—Metabolism—TPO—hypothyroidism	3.57e-05	0.000693	CbGpPWpGaD
Loperamide—CALM2—Metabolism—TPO—hypothyroidism	3.57e-05	0.000693	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—VAV3—hypothyroidism	3.56e-05	0.000689	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CLTC—hypothyroidism	3.55e-05	0.000688	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—POMC—hypothyroidism	3.53e-05	0.000685	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—IYD—hypothyroidism	3.5e-05	0.000679	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TRH—hypothyroidism	3.5e-05	0.000678	CbGpPWpGaD
Loperamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.44e-05	0.000668	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—AVP—hypothyroidism	3.43e-05	0.000664	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ATP5O—hypothyroidism	3.42e-05	0.000663	CbGpPWpGaD
Loperamide—CYP2C8—Biological oxidations—POMC—hypothyroidism	3.41e-05	0.000661	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—IYD—hypothyroidism	3.3e-05	0.00064	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—VAV3—hypothyroidism	3.23e-05	0.000626	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TPO—hypothyroidism	3.21e-05	0.000623	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—POMC—hypothyroidism	3.18e-05	0.000617	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TSHB—hypothyroidism	3.12e-05	0.000605	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TSHR—hypothyroidism	3.12e-05	0.000605	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—VAV3—hypothyroidism	3.12e-05	0.000605	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AVP—hypothyroidism	3.11e-05	0.000603	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.08e-05	0.000598	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TRH—hypothyroidism	3.07e-05	0.000595	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AVP—hypothyroidism	3e-05	0.000582	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CLTC—hypothyroidism	3e-05	0.000582	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—POMC—hypothyroidism	2.99e-05	0.000579	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.98e-05	0.000578	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	2.98e-05	0.000578	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ATP5O—hypothyroidism	2.98e-05	0.000578	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	2.98e-05	0.000577	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—IGF1—hypothyroidism	2.96e-05	0.000574	CbGpPWpGaD
Loperamide—CALM3—Immune System—CLTC—hypothyroidism	2.87e-05	0.000557	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—VAV3—hypothyroidism	2.83e-05	0.000549	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ATP5O—hypothyroidism	2.81e-05	0.000544	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TPO—hypothyroidism	2.8e-05	0.000543	CbGpPWpGaD
Loperamide—CYP2D6—Biological oxidations—POMC—hypothyroidism	2.8e-05	0.000543	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SH2B3—hypothyroidism	2.78e-05	0.000539	CbGpPWpGaD
Loperamide—CALM2—Immune System—CLTC—hypothyroidism	2.78e-05	0.000539	CbGpPWpGaD
Loperamide—CALM1—Immune System—CLTC—hypothyroidism	2.78e-05	0.000539	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TSHB—hypothyroidism	2.73e-05	0.00053	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TSHR—hypothyroidism	2.73e-05	0.00053	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AVP—hypothyroidism	2.73e-05	0.000529	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TRH—hypothyroidism	2.72e-05	0.000527	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TPO—hypothyroidism	2.64e-05	0.000512	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—VAV3—hypothyroidism	2.64e-05	0.000511	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TRH—hypothyroidism	2.63e-05	0.00051	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TRH—hypothyroidism	2.63e-05	0.00051	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.63e-05	0.000509	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TRH—hypothyroidism	2.59e-05	0.000503	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—VAV3—hypothyroidism	2.58e-05	0.0005	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AVP—hypothyroidism	2.54e-05	0.000492	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—VAV3—hypothyroidism	2.5e-05	0.000484	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—VAV3—hypothyroidism	2.5e-05	0.000484	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SH2B3—hypothyroidism	2.44e-05	0.000473	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TSHB—hypothyroidism	2.42e-05	0.00047	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TSHR—hypothyroidism	2.42e-05	0.00047	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—VAV3—hypothyroidism	2.39e-05	0.000464	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TSHB—hypothyroidism	2.34e-05	0.000454	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TSHB—hypothyroidism	2.34e-05	0.000454	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TSHR—hypothyroidism	2.34e-05	0.000454	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TSHR—hypothyroidism	2.34e-05	0.000454	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—VAV3—hypothyroidism	2.32e-05	0.000451	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TSHB—hypothyroidism	2.31e-05	0.000448	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TSHR—hypothyroidism	2.31e-05	0.000448	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AVP—hypothyroidism	2.31e-05	0.000447	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—POMC—hypothyroidism	2.28e-05	0.000441	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—VAV3—hypothyroidism	2.25e-05	0.000436	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—VAV3—hypothyroidism	2.25e-05	0.000436	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—IYD—hypothyroidism	2.16e-05	0.000418	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.07e-05	0.000402	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—POMC—hypothyroidism	2.07e-05	0.000401	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PRL—hypothyroidism	2.06e-05	0.0004	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SH2B3—hypothyroidism	2.06e-05	0.000399	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—POMC—hypothyroidism	2e-05	0.000387	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VAV3—hypothyroidism	1.91e-05	0.00037	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CLTC—hypothyroidism	1.86e-05	0.00036	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AVP—hypothyroidism	1.84e-05	0.000356	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ATP5O—hypothyroidism	1.83e-05	0.000356	CbGpPWpGaD
Loperamide—CYP3A4—Biological oxidations—POMC—hypothyroidism	1.83e-05	0.000355	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—POMC—hypothyroidism	1.81e-05	0.000351	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PRL—hypothyroidism	1.81e-05	0.000351	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CLTC—hypothyroidism	1.8e-05	0.000348	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CLTC—hypothyroidism	1.8e-05	0.000348	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—TSHB—hypothyroidism	1.76e-05	0.000341	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TPO—hypothyroidism	1.73e-05	0.000335	CbGpPWpGaD
Loperamide—CALM3—Metabolism—TSHB—hypothyroidism	1.71e-05	0.000332	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—POMC—hypothyroidism	1.69e-05	0.000327	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VAV3—hypothyroidism	1.67e-05	0.000324	CbGpPWpGaD
Loperamide—CALM1—Metabolism—TSHB—hypothyroidism	1.65e-05	0.000321	CbGpPWpGaD
Loperamide—CALM2—Metabolism—TSHB—hypothyroidism	1.65e-05	0.000321	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.63e-05	0.000316	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AVP—hypothyroidism	1.61e-05	0.000312	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TRH—hypothyroidism	1.6e-05	0.000311	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IGF1—hypothyroidism	1.59e-05	0.000308	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	1.57e-05	0.000304	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TRH—hypothyroidism	1.55e-05	0.000301	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TRH—hypothyroidism	1.55e-05	0.000301	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IGF1—hypothyroidism	1.54e-05	0.000298	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IGF1—hypothyroidism	1.54e-05	0.000298	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—POMC—hypothyroidism	1.53e-05	0.000297	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PRL—hypothyroidism	1.53e-05	0.000296	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PIK3C2A—hypothyroidism	1.52e-05	0.000296	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—TSHB—hypothyroidism	1.49e-05	0.000289	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—VAV3—hypothyroidism	1.48e-05	0.000287	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PIK3C2A—hypothyroidism	1.47e-05	0.000286	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PIK3C2A—hypothyroidism	1.47e-05	0.000286	CbGpPWpGaD
Loperamide—CALM3—Immune System—PRL—hypothyroidism	1.46e-05	0.000284	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—VAV3—hypothyroidism	1.43e-05	0.000278	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—VAV3—hypothyroidism	1.43e-05	0.000278	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TSHB—hypothyroidism	1.43e-05	0.000277	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TSHR—hypothyroidism	1.43e-05	0.000277	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AVP—hypothyroidism	1.43e-05	0.000277	CbGpPWpGaD
Loperamide—CALM1—Immune System—PRL—hypothyroidism	1.42e-05	0.000274	CbGpPWpGaD
Loperamide—CALM2—Immune System—PRL—hypothyroidism	1.42e-05	0.000274	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VAV3—hypothyroidism	1.41e-05	0.000274	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TSHB—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TSHB—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TSHR—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TSHR—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AVP—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AVP—hypothyroidism	1.38e-05	0.000268	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AVP—hypothyroidism	1.36e-05	0.000264	CbGpPWpGaD
Loperamide—CALM3—Immune System—VAV3—hypothyroidism	1.35e-05	0.000262	CbGpPWpGaD
Loperamide—CALM3—Disease—PRL—hypothyroidism	1.35e-05	0.000262	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	1.33e-05	0.000257	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—SLC5A5—hypothyroidism	1.32e-05	0.000255	CbGpPWpGaD
Loperamide—CALM2—Immune System—VAV3—hypothyroidism	1.31e-05	0.000254	CbGpPWpGaD
Loperamide—CALM1—Immune System—VAV3—hypothyroidism	1.31e-05	0.000254	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.31e-05	0.000254	CbGpPWpGaD
Loperamide—CALM2—Disease—PRL—hypothyroidism	1.31e-05	0.000253	CbGpPWpGaD
Loperamide—CALM1—Disease—PRL—hypothyroidism	1.31e-05	0.000253	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—TSHB—hypothyroidism	1.3e-05	0.000251	CbGpPWpGaD
Loperamide—CALM3—Metabolism—SLC5A5—hypothyroidism	1.28e-05	0.000248	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SH2B3—hypothyroidism	1.27e-05	0.000247	CbGpPWpGaD
Loperamide—CALM2—Metabolism—SLC5A5—hypothyroidism	1.24e-05	0.00024	CbGpPWpGaD
Loperamide—CALM1—Metabolism—SLC5A5—hypothyroidism	1.24e-05	0.00024	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SH2B3—hypothyroidism	1.23e-05	0.000239	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SH2B3—hypothyroidism	1.23e-05	0.000239	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TSHB—hypothyroidism	1.22e-05	0.000237	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—POMC—hypothyroidism	1.22e-05	0.000237	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IGF1—hypothyroidism	1.17e-05	0.000228	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.16e-05	0.000224	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—SLC5A5—hypothyroidism	1.11e-05	0.000216	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	1.09e-05	0.000211	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—POMC—hypothyroidism	1.07e-05	0.000208	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IGF1—hypothyroidism	1.03e-05	0.0002	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—SLC5A5—hypothyroidism	9.7e-06	0.000188	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—POMC—hypothyroidism	9.48e-06	0.000184	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRL—hypothyroidism	9.46e-06	0.000183	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—POMC—hypothyroidism	9.17e-06	0.000178	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—POMC—hypothyroidism	9.17e-06	0.000178	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRL—hypothyroidism	9.15e-06	0.000177	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRL—hypothyroidism	9.15e-06	0.000177	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—SLC5A5—hypothyroidism	9.15e-06	0.000177	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—POMC—hypothyroidism	9.05e-06	0.000175	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VAV3—hypothyroidism	8.75e-06	0.00017	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IGF1—hypothyroidism	8.71e-06	0.000169	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VAV3—hypothyroidism	8.46e-06	0.000164	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VAV3—hypothyroidism	8.46e-06	0.000164	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AVP—hypothyroidism	8.43e-06	0.000163	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AVP—hypothyroidism	8.15e-06	0.000158	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AVP—hypothyroidism	8.15e-06	0.000158	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TSHB—hypothyroidism	7.99e-06	0.000155	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	7.12e-06	0.000138	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—POMC—hypothyroidism	6.88e-06	0.000133	CbGpPWpGaD
Loperamide—CALM3—Metabolism—POMC—hypothyroidism	6.7e-06	0.00013	CbGpPWpGaD
Loperamide—CALM2—Metabolism—POMC—hypothyroidism	6.48e-06	0.000126	CbGpPWpGaD
Loperamide—CALM1—Metabolism—POMC—hypothyroidism	6.48e-06	0.000126	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC5A5—hypothyroidism	5.98e-06	0.000116	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—hypothyroidism	5.83e-06	0.000113	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—hypothyroidism	5.6e-06	0.000109	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—hypothyroidism	5.42e-06	0.000105	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—hypothyroidism	5.42e-06	0.000105	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IGF1—hypothyroidism	5.39e-06	0.000104	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IGF1—hypothyroidism	5.21e-06	0.000101	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IGF1—hypothyroidism	5.21e-06	0.000101	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—hypothyroidism	5.08e-06	9.85e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—hypothyroidism	4.78e-06	9.28e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—hypothyroidism	3.13e-06	6.07e-05	CbGpPWpGaD
